Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 2
1981 4
1982 2
1983 1
1984 3
1985 6
1986 5
1987 2
1988 5
1989 5
1990 4
1991 8
1992 7
1993 5
1994 8
1995 8
1996 7
1997 6
1998 14
1999 17
2000 15
2001 14
2002 12
2003 15
2004 18
2005 17
2006 23
2007 17
2008 16
2009 13
2010 19
2011 14
2012 26
2013 28
2014 31
2015 35
2016 28
2017 28
2018 28
2019 29
2020 29
2021 29
2022 26
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Focal segmental glomerulosclerosis 6"
Page 1
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, Friedman DJ, Bramham K, Campbell K, Knebelmann B, Barisoni L, Falk RJ, Gipson DS, Lipkowitz MS, Ojo A, Bunnage ME, Pollak MR, Altshuler D, Chertow GM; VX19-147-101 Study Group. Egbuna O, et al. N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396. N Engl J Med. 2023. PMID: 36920755 Clinical Trial.
We then conducted a single-group, open-label, phase 2a clinical study in which inaxaplin was administered to participants who had two APOL1 variants, biopsy-proven focal segmental glomerulosclerosis, and proteinuria (urinary protein-to-creatinine ratio of 0.7 …
We then conducted a single-group, open-label, phase 2a clinical study in which inaxaplin was administered to participants who had two APOL1 …
Recurrence of FSGS after Kidney Transplantation in Adults.
Uffing A, Pérez-Sáez MJ, Mazzali M, Manfro RC, Bauer AC, de Sottomaior Drumond F, O'Shaughnessy MM, Cheng XS, Chin KK, Ventura CG, Agena F, David-Neto E, Mansur JB, Kirsztajn GM, Tedesco-Silva H Jr, Neto GMV, Arias-Cabrales C, Buxeda A, Bugnazet M, Jouve T, Malvezzi P, Akalin E, Alani O, Agrawal N, La Manna G, Comai G, Bini C, Muhsin SA, Riella MC, Hokazono SR, Farouk SS, Haverly M, Mothi SS, Berger SP, Cravedi P, Riella LV. Uffing A, et al. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):247-256. doi: 10.2215/CJN.08970719. Epub 2020 Jan 23. Clin J Am Soc Nephrol. 2020. PMID: 31974287 Free PMC article.
We therefore aimed to determine the incidence, predictors, and treatment response of recurrent FSGS in a large cohort of kidney transplant recipients. ...Multivariable Cox regression revealed a higher risk for recurrence with older age at native kidney disease onset (hazar …
We therefore aimed to determine the incidence, predictors, and treatment response of recurrent FSGS in a large cohort of kidney trans …
Glomerulonephritis Histopathological Pattern Change.
AlYousef A, AlSahow A, AlHelal B, Alqallaf A, Abdallah E, Abdellatif M, Nawar H, Elmahalawy R. AlYousef A, et al. BMC Nephrol. 2020 May 18;21(1):186. doi: 10.1186/s12882-020-01836-3. BMC Nephrol. 2020. PMID: 32423387 Free PMC article.
It helps in identifying the exact specific diagnosis, assessing the level of disease activity and severity, and hence aids in proper therapy and helps predicting prognosis. There is a global change of pattern of glomerular disease over the last five decades. ...Immunoglobu …
It helps in identifying the exact specific diagnosis, assessing the level of disease activity and severity, and hence aids in proper therapy …
Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker.
Menon R, Otto EA, Hoover P, Eddy S, Mariani L, Godfrey B, Berthier CC, Eichinger F, Subramanian L, Harder J, Ju W, Nair V, Larkina M, Naik AS, Luo J, Jain S, Sealfon R, Troyanskaya O, Hacohen N, Hodgin JB, Kretzler M, Kpmp KPMP; Nephrotic Syndrome Study Network (NEPTUNE). Menon R, et al. JCI Insight. 2020 Mar 26;5(6):e133267. doi: 10.1172/jci.insight.133267. JCI Insight. 2020. PMID: 32107344 Free PMC article.
Transcripts defining glomerular endothelial cells (GEC) were evaluated in biopsies from patients with 10 different glomerular diseases in the NEPTUNE and European Renal cDNA Bank (ERCB) cohort studies. Highest GEC scores were observed in patients with focal …
Transcripts defining glomerular endothelial cells (GEC) were evaluated in biopsies from patients with 10 different glomerular diseases in th …
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N. Hansrivijit P, et al. BMC Nephrol. 2020 Apr 15;21(1):134. doi: 10.1186/s12882-020-01797-7. BMC Nephrol. 2020. PMID: 32293308 Free PMC article.
BACKGROUND: Use of rituximab (RTX) for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is widely described in children. ...From the analysis of five studies with FSGS patients (n = 51), the overall remission rate and relapse rate of …
BACKGROUND: Use of rituximab (RTX) for focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) is wi …
Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study.
Ma X, Fang L, Sheng L, Zhou X, Bai S, Zang X, Wang Y, Li M, Lv Z, Zhong Q, Yang X, Wang Y, Hu Y, Yan D, Shi Y, Chen H, Li J, Tao M, Zhuang S, Wang Y, Liu N. Ma X, et al. Ren Fail. 2023 Dec;45(1):2237124. doi: 10.1080/0886022X.2023.2237124. Ren Fail. 2023. PMID: 37482915 Free PMC article.
Patients enrolled were divided into two groups according to pathological pattern: 20 patients as a group of podocytopathy (including minimal change disease [MCD] and focal and segmental glomerulosclerosis [FSGS]), and 26 patients as membranous nephropathy (MN …
Patients enrolled were divided into two groups according to pathological pattern: 20 patients as a group of podocytopathy (including minimal …
Focal segmental glomerulosclerosis in children.
Jellouli M, Abidi K, Askri M, Ferjani M, Naija O, Hammi Y, Goucha R, Gargah T. Jellouli M, et al. Tunis Med. 2016 May;94(5):356-359. Tunis Med. 2016. PMID: 27801486
Background Focal segmental glomerulosclerosis (FSGS) represents 20% of nephrotic syndrome in children. ...Results There were 30 children, 16 boys and 14 girls. The mean age was 7 4 years. Nephrotic syndrome was observed in 26 patients, hematuria was no …
Background Focal segmental glomerulosclerosis (FSGS) represents 20% of nephrotic syndrome in children. ...Results There …
Current and Future Therapeutical Options in Alport Syndrome.
Reiterová J, Tesař V. Reiterová J, et al. Int J Mol Sci. 2023 Mar 14;24(6):5522. doi: 10.3390/ijms24065522. Int J Mol Sci. 2023. PMID: 36982595 Free PMC article. Review.
Endothelin type A receptor and angiotensin II type 1 receptor combined inhibitors, and lipid-lowering agents are used in ongoing studies in patients with AS and focal segmental glomerulosclerosis (FSGS). Hydroxychloroquine in AS is studied in a clinical trial …
Endothelin type A receptor and angiotensin II type 1 receptor combined inhibitors, and lipid-lowering agents are used in ongoing studies in …
Predictors of long-term outcomes in pediatric focal segmental glomerulosclerosis.
Peng Y, Gao C, Xu C, Wu H, Wang M, Wang R, Wei Y, Li X, Ju T, Xia Z, Zhang P. Peng Y, et al. J Nephrol. 2023 Jul;36(6):1581-1590. doi: 10.1007/s40620-023-01631-x. Epub 2023 Apr 7. J Nephrol. 2023. PMID: 37027095
BACKGROUND: Available data on primary focal segmental glomerulosclerosis (FSGS) in children usually report on short follow-up and small samples. ...ROC curve analysis showed an excellent diagnostic yield of the Columbia classification. The combination of Colu …
BACKGROUND: Available data on primary focal segmental glomerulosclerosis (FSGS) in children usually report on short fol …
Clinical Course of Adult FSGS and Minimal Change Disease in North American and Japanese Cohorts.
Ozeki T, Gillespie BW, Larkina M, Maruyama S, Alakwaa F, Kretzler M, Mariani LH. Ozeki T, et al. Kidney360. 2023 Jul 1;4(7):924-934. doi: 10.34067/KID.0000000000000133. Epub 2023 May 3. Kidney360. 2023. PMID: 37131280 Free PMC article.
N-KDR participants were older (median 56 versus 43 years) and demonstrated greater levels of urine protein creatinine ratio (7.73 versus 6.65) and hypoalbuminemia (1.6 versus 2.2 mg/dl). N-KDR participants showed higher proportion of CR (overall: 89.2 versus 62.9%; …
N-KDR participants were older (median 56 versus 43 years) and demonstrated greater levels of urine protein creatinine ratio (7.73 versus …
598 results